Group One Trading’s Vera Therapeutics VERA Stock Holding History

Group One Trading’s Portfolio VERA Stock Details VERA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.73M	Buy	84,505 +16,407	+24%	+$574K	﹤0.01%	1881
2026 Q2	$2.92M	Buy	+68,098	New	+$2.54M	﹤0.01%	1861
2025 Q3	–	Sell	-11,360	Closed	-$263K	–	9211
2025 Q2	$268K	Buy	+11,360	New	+$255K	﹤0.01%	4041
2025 Q1	–	Sell	-6,992	Closed	-$225K	–	8419
2024 Q4	$296K	Buy	+6,992	New	+$310K	﹤0.01%	3599
2024 Q3	–	Sell	-12,058	Closed	-$458K	–	7420
2024 Q2	$436K	Buy	+12,058	New	+$478K	﹤0.01%	2693

Other funds holding VERA

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $109B AUM 51.53% 1-Year Est. Return

TimesSquare Capital Management New York $6.12B AUM 30.01% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Group One Trading's VERA Position: Q3 2026 in Review

Group One Trading increased its Vera Therapeutics (VERA) stake by 24% in Q3 2026, buying an estimated $574K and bringing the position to 84,505 shares worth $2.73M. The position accounts for ﹤0.01% of the portfolio, ranked #1881.

Group One Trading first reported a position in VERA in Q2 2024 and has held it in 5 quarters since. The position peaked at $2.92M in Q2 2026. 91 funds tracked by Wall St. Rank hold VERA as of Q3 2026.

Group One Trading held 84,505 shares of Vera Therapeutics worth $2.73M as of Q3 2026.
Group One Trading bought 16,407 Vera Therapeutics shares in Q3 2026, an estimated $574K.
Vera Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #1881 holding.
Group One Trading first reported a position in Vera Therapeutics in Q2 2024 and has held it in 5 quarters since.
Group One Trading's Vera Therapeutics position peaked at $2.92M in Q2 2026.
91 funds tracked by Wall St. Rank held Vera Therapeutics as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.